Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety study of an intestinal lipase inhibitor for adult obesity
RBR-4f6sh5Phase 3Not yet recruiting
- Sponsor
- Marcio Antonio Pereira Clinica Medica de Endocrinologia
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of orlistat in obesity (2 arms), sponsored by Marcio Antonio Pereira Clinica Medica de Endocrinologia. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
orlistat
03
Conditions
obesity
Beyond the preview
Go deeper on RBR-4f6sh5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4f6sh5.